Hydrogel nanoparticles(10)

[108]M.Tanihara,Y.Suzuki,Y.Nishimura,K.Suzuki,Y.Kakimaru,Y.Fukunishi,A novel microbial infection-responsive drug delivery system,J.Pharm.Sci.88(1999)510–514. [109]J.Pluta,B.Karolewicz,Hydrogels:properties and application in the technology of drug form.II.Possibilities of use of hydrogels as active substance carriers,Polim.

Med.34(3)(2004)63–81.

[110]D.Kanjickal,S.Lopina,M.M.Evancho Chapman,S.Schmidt, D.Donovan, Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins, J.Biomed.Mater.Res.A.74(3)(2005)454–460.

[111]H.E.Junginger,Mucoadhesive hydrogels,Pharm.Ind.53(1991)1056–1065. [112]K.Knuth,M.Amiji,J.R.Robinson,Hydrogel delivery systems for vaginal and oral applications,Adv.Drug Deliv.Rev.11(1993)137–167.

[113]T.Nagai,Y.Machida,Buccal delivery systems using hydrogels,Adv.Drug Deliv.

Rev.11(1993)179–191.

[114]H.Park,K.Park,Biocompatibility issues of implantable drug delivery systems, Pharm.Res.13(1996)1770–1776.

[115]X.Yang,J.R.Robinson,Bioadhesion in mucosal drug delivery,in:T.Okano(Ed.), Biorelated Polymers and Gels,Academic Press,San Diego,CA,1998,pp.135–192. [116]A.Gutowska,J.S.Bark,I.C.Kwon,Y.H.Bae,S.W.Kim,Squeezing hydrogels for controlled oral drug delivery,J.Control.Release48(1997)141–148.

[117]F.A.Dorkoosh,J.Coos Verhoef,M.H.Ambagts,M.Ra?ee Tehrani,G.Borchard,

H.E.Junginger,Peroral delivery systems based on superporous hydrogel poly-

mers:release characteristics for the peptide drugs buserelin,octreotide and insulin,Eur.J.Pharm.Sci.15(5)(2002)433–439.

[118]P.Gyselinck,E.Schacht,R.Van Severen,P.Braeckman,Preparation and char-acterization of therapeutic hydrogels as oral dosage forms,Acta Pharm,Technol.

29(1)(1983)9–12.

[119]N.Garcia Gonzalez,I.W.Kellaway,H.Blanco Fuente,S.Anguiano Igea,J.Blanco Mendez,Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly(acrylic acid)crosslinked with sucrose,Int.J.Pharm.100(1993) 65–70.

[120]T.L.Bowersock,H.HogenEsch,M.Suckow,R.E.Porter,K.Park,Oral vaccination with alginate microsphere systems,J.Control.Release39(1996)209–220. [121]R.Jeyanthi,B.Nagarajan,K.Panduranga Rao,Solid tumor chemotherapy using implantable collagen-poly(HEMA)hydrogel containing5-?uorouracil,J.Pharm.

Pharmacol.43(1991)60–62.

[122]E.Beyssac,C.Bregni,J.-M.Aiache,S.Gerula,E.Smolko,Hydrogel implants for methotrexate obtained by ionizing radiation,Drug Dev.Ind.Pharm.22(1996) 439–444.

[123]O.Franssen,O.P.Vos,W.E.Hennink,Delayed release of a model protein from enzymatically-degrading dextran hydrogels,J.Control.Release44(1997)237–245. [124]W.E.Hennink,O.Franssen,W.N.E.van Dijk-Wolthuis,H.Talsma,Dextran hydrogels for the controlled release of proteins,J.Control.Release48(1997) 107–114.

[125]Y.Y.Wang,C.T.Hong,W.T.Chiu,J.Y.Fang,In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydro gels,Int.J.Pharm224(1–2)(2001) 89–104.

[126]A.Nangia,C.T.Hung,Analysis of preparation of dextran hydrogel membranes as a wound dressing,Drug.Dev.Ind.Pharm.17(12)(1991)1609–1624.

[127]R.V.Padmanabhan,J.B.Phipps,ttin,R.J.Sawchuk,In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone,J.Control.

Release11(1990)123–135.

[128]L.L.H.Chen,Y.W.Chien,Transdermal iontophoretic permeation of luteinizing hormone releasing hormone:characterization of electric parameters,J.Control.

Release40(1996)187–198.

[129]J.Y.Fang,Y.B.Huang,H.H.Lin,Y.H.Tsai,Transdermal iontophoresis of sodium nonivamide acetate.IV.Effect of polymer formulations,Int.J.Pharm.173(1998) 127–140.

[130]H.Park,K.Park,D.Kim,Preparation and swelling behavior of chitosan-based superporous hydrogels for gastric retention application,J.Biomed.Mater.Res.A.

76(1)(2006)144–150.

[131]V.R.Patel,M.M.Amiji,Preparation and characterization of freeze dried chitosan-poly(ethylene oxide)hydrogels for site-speci?c antibiotic delivery in the stomach,Pharm.Res.13(1996)588–593.

[132]Y.Akiyama,H.L.Lueβen,A.G.de Boer,J.C.Verhoef,H.E.Junginger,Novel peroral dosage forms with protease inhibitory activities.II.Design of fast dissolving poly (acrylate)and controlled drug releasing capsule formulations with trypsin inhibiting properties,Int.J.Pharm.138(1996)13–23.

[133]A.M.Lowman,M.Morishita,M.Kajita,T.Nagai,N.A.Peppas,Oral delivery of insulin using pH-responsive complexation gels,J.Pharm.Sci.88(1999)933–937. [134]H.Brondsted,L.Hovgaard,L.Simonsen,Dextran hydrogels for colon-speci?c drug parative release study of hydrocortisone and prednisolone sodium phosphate,STP Pharma.Sci.5(1)(1995)65–69.

[135]L.Vervoort,I.Vinckier,P.Moldenaers,G.Van den Mooter,P.Augustijns,R.Kinget, Inulin hydrogels as carriers for colonic drug targeting.Rheological characterization of the hydrogel formation and the hydrogel network,J.Pharm.Sci.88(1999)209–214. [136]K.Morimoto,A.Nagayasu,S.Fukanoki,K.Morisaka,Y.Ikada,Evaluation of polyvinyl alcohol hydrogel as a sustained-release vehicle for rectal administra-tion of indomethacin,Pharm,Res.6(1989)338–341.

[137]Z.Zatloukal,Sterilized ophthalmic hydrogels with hydroxypropylmethyl cellu-lose,Cesk.Farm.38(1989)368–370.

[138]S.Burgalassi,P.Chetoni,M.F.Saettone,Hydrogels for ocular delivery of pilocarpine:preliminary evaluation in rabbits of the in?uence of viscosity and of drug solubility,Eur.J.Pharm.Biopharm.42(6)(1996)385–392.

[139]S.Cohen,E.Lobel,A.Trevgoda,T.Peled,A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye,J.Control.Release 44(1997)201–208.[140]J.Wu,W.Wei,L.Y.Wang,Z.G.Su,G.H.Ma,A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol)for nasal drug delivery system, Biomaterials28(13)(2007)2220–2232.

[141]N.S.Cameron,F.G.Morin,A.Eisenberg,G.R.Brown,Poly(N,N,N-trimethylammo-niumalkyl acrylamide chloride)based hydrogels for serum cholesterol reduction, Biomacromolecules5(1)(2004)24–31.

[142]O.J.D'Cruz, F.M.Uckun,Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles,Contraception64(2)(2001)113–123. [143]K.Nomura,K.Murakami,M.Shozu,T.Nakama,N.Yui,M.Inoue,Local application of danazol-loaded hyaluronic acid hydrogel to endometriosis in a rat model, Fertil.Steril.85(Suppl.1)(2006)1157–1167.

[144]M.Patel,T.Shah,A.Amin,Therapeutic opportunities in colon-speci?c drug-delivery systems,Crit.Rev.Ther.Drug Carr.Syst.24(2007)147–202.

[145]Y.Kato,H.Onishi,Y.Machida,Application of chitin and chitosan derivatives in the pharmaceutical?eld,Curr.Pharm.Biotechnol.4(2003)303–309.

[146]M.Prabaharan,J.F.Mano,Stimuli-responsive hydrogels based on polysaccharides incorporated with thermo-responsive polymers as novel biomaterials,Macro-mol.Biosci.6(2006)991–1008.

[147]M.George,T.E.Abraham,Polyionic hydrocolloids for the intestinal delivery of protein drugs:alginate and chitosan,J.Control.Release114(2006)1–14. [148]S.Sharma,J.Kulkarni,A.P.Pawar,Permeation enhancers in the transmucosal delivery of macromolecules,Pharmazie61(2006)495–504.

[149]A.Bernkop-Schnürch,G.Walker,Multifunctional matrices for oral peptide delivery,Crit.Rev.Ther.Drug Carr.Syst.18(2001)459–501.

[150]I.M.Van der Lubben,J.C.Verhoef,G.Borchard,H.E.Junginger,Chitosan for mucosal vaccination,Adv.Drug Deliv.Rev.52(2001)139–144.

[151]T.G.Shutava,Y.M.Lvov,Nano-engineered microcapsules of tannic acid and chitosan for protein encapsulation,J.Nanosci.Nanotechnol.6(2006)1655–1661. [152]Y.F.Fan,Y.N.Wang,Y.G.Fan,J.B.Ma,Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorp-tion,Int.J.Pharm.324(2006)158–167.

[153]R.Pandey,Z.Ahmad,S.Sharma,G.K.Khuller,Nano-encapsulation of azole antifungals:potential applications to improve oral drug delivery,Int.J.Pharm.

301(2005)268–276.

[154]C.M.Lehr,J.A.Bowstra, E.H.Schacht,H.E.Junginger,In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers,Int.J.

Pharm.78(1992)43–48.

[155]K.A.Janes,P.Calvo,M.J.Alonso,Polysaccharide colloidal particles as delivery systems for macromolecules,Adv.Drug Del.Rev.47(2001)83–97.

[156]P.Artursson,T.Lindmark,S.S.Davis,L.Illum,Effect of chitosan on the permeability of monolayers of intestinal epithelial cells(Caco-2),Pharm.Res.

11(1994)1358–1361.

[157]G.Borchard,H.L.Lueben,G.A.De Boer,J.Coos Verhoef,C.M.Lehr,H.E.Junginger, The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III:Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro,J.Control.Rel.39(1996)131–138.

[158]N.G.M.Schipper,K.M.Varum,P.Artursson,Chitosan as absorption enhancers for poorly absorbable drugs1:In?uence of molecular weight and degree of acetylation on drug transport across human intestinal epithelia(Caco-29cells), Pharm.Res.13(1996)1686–1692.

[159]N.G.M.Schipper,S.Olsson,A.J.Hoostraate,A.G.De Boer,K.M.Varum,P.Artursson, Chitosan as absorption enhancers for poorly absorbable drugs2:Mechanism of absorption enhancement,Pharm.Res.14(1997)923–929.

[160]N.G.M.Schipper,K.M.Varum,P.Stenberg,G.Ockind,H.Lennernäis,P.Artursson, Chitosan as absorption enhancers for poorly absorbable drugs3:in?uence of mucus on absorption enhancement,Eur.J.Pharm.Sci.8(1999)335–343. [161]J.Knapczyk,L.Krowczynski,J.Krzck,M.Brzeski,E.Nirnberg,D.Schenk,H.Struszcyk, Requirements of chitosan for pharmaceutical and biomedical applications,in:G.

Skak-Braek,T.Anthonsen,P.Sandford(Eds.),Chitin and Chitosan:Sources, Chemistry,Biochemistry,Physical Properties and Applications,Elsevier,London, 1989,pp.657–663.

[162]S.Hirano,H.Seino,I.Akiyama,I.Nonaka,Chitosan:a biocompatible material for oral and intravenous administration,in:C.G.Gebelein,R.L.Dunn(Eds.),Progress in Biomedical Polymers,Plenum Press,New York,1990,pp.283–289.

[163]S.Hirano,H.Seino,Y.Akiyama,I.Nonaka,Biocompatibility of chitosan by oral and intravenous administration,Polym.Eng.Sci.59(1989)897–901.

[164]P.C.Bersch,B.Nies,A.Liebendorfer,Evaluation of the biological properties of different wound dressing materials,J.Mater.Sci.Med.6(1995)231–240. [165]V.Dodane,D.Vilivalam,Pharmaceutical applications of chitosan,Pharm.Sci.

Technol.Today16(1998)246–253.

[166]W.Paul,C.Sharma,Chitosan,a drug carrier for the21st century,S.T.P.Pharm.Sci.

10(2000)5–22.

[167]H.J.Watzke,C.Dieschbourg,Novel silica-biopolymer nanocomposites:the silica sol–gel process in biopolymer organogels,Adv.Colloids Interface Sci.50(1994)1–14. [168]Y.Ohya,M.Shiratani,H.Kobayashi,T.Ouchi,Release behavior of5-?uorouracil from chitosan-gel nanospheres immobilizing5-?uorouracil coated with poly-saccharides and their cell speci?c cytotoxicity,Pure Appl.Chem.31(1994) 629–642.

[169]S.Shirashi,T.Imai,M.Otagiri,Controlled release of indomethacin by chitosan–polyelectrolyte complex:optimization and in vivo:in vitro evaluation,J.Control.

Release25(1993)217–225.

[170]P.Calvo,C.Remunan-Lopez,J.L.Vila-Jata,M.J.Alonso,Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers,J.Appl.Polym.Sci.63(1997) 125–132.

[171]X.Z.Shu,K.J.Zhu,A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery,Int.J.Pharm.201(2000)51–58.

1647

M.Hamidi et al./Advanced Drug Delivery Reviews60(2008)1638–1649

百度搜索“77cn”或“免费范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读，免费范文网，提供经典小说教育文库Hydrogel nanoparticles(10)在线全文阅读。